1.
Rev. Soc. Bras. Med. Trop
;
49(6): 774-776, Dec. 2016. graf
Article
Dans Anglais
| LILACS
| ID: biblio-1041383
Résumé
Abstract INTRODUCTION: Intralesional treatment for cutaneous leishmaniasis has been applied for over 30 years at the Oswaldo Cruz Foundation, Rio de Janeiro, with good therapeutic results and without relevant systemic toxicity. METHODS Meglumine antimoniate was injected subcutaneously, using a long medium-caliber needle (for example, 30mm × 0.8mm); patients received 1-3 injections, with 15-day intervals. RESULTS The technique is described in detail sufficient to enable replication. CONCLUSIONS: The treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate is a simple, effective, and safe technique, which may be used in basic healthcare settings.
Sujets)
Humains , Composés organométalliques/administration et posologie , Leishmaniose cutanée/traitement médicamenteux , Méglumine/administration et posologie , Antiprotozoaires/administration et posologie , Injections intralésionnelles/normes , Antimoniate de méglumine
2.
Arch. argent. dermatol
;
43(6): 411-7, nov.-dic. 1993. ilus, tab
Article
Dans Espagnol
| LILACS
| ID: lil-129861